JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB262889

Anti-SGPP1 antibody

Be the first to review this product! Submit a review

|

(1 Publication)

Rabbit Polyclonal SGPP1 antibody. Suitable for ICC/IF and reacts with Human samples. Cited in 1 publication. Immunogen corresponding to Recombinant Fragment Protein within Human SGPP1 aa 250-300.

View Alternative Names

SPP1, SGPP1, Sphingosine-1-phosphate phosphatase 1, SPPase1, Spp1, hSPP1, hSPPase1, Sphingosine-1-phosphatase 1, Sphingosine-1-phosphate phosphohydrolase 1, SPP-1

1 Images
Immunocytochemistry/ Immunofluorescence - Anti-SGPP1 antibody (AB262889)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-SGPP1 antibody (AB262889)

PFA-fixed, Triton X-100 permeabilized human A-431 ( human epidermoid carcinoma cell line) cells stained for SGPP1 (green) using ab262889 at 4 μg/ml in ICC/IF. The cytoskeketon is counterstained in Red.

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

ICC/IF

applications

Immunogen

Recombinant Fragment Protein within Human SGPP1 aa 250-300. The exact immunogen used to generate this antibody is proprietary information.

Q9BX95

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1-4 µg/mL", "ICCIF-species-notes": "<p>Fixation/Permeabilization: PFA/Triton X-100</p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
pH: 7.2 Preservative: 0.02% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine)
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

SGPP1 also known as sphingosine-1-phosphate phosphatase 1 is an enzyme that dephosphorylates sphingosine-1-phosphate (S1P) to sphingosine. This enzymatic activity helps regulate the levels of S1P a bioactive lipid involved in various cellular processes. The molecular mass of SGPP1 is approximately 50 kDa. SGPP1 is expressed in a variety of tissues including the liver brain and kidneys indicating its widespread role in the body.
Biological function summary

SGPP1 plays an important role in controlling the sphingolipid signaling pathway influencing cell growth survival and migration. It is not part of a larger complex but operates through interaction with S1P and its receptors. By removing phosphate groups from S1P SGPP1 reduces the signaling activity of this lipid mediator therefore influencing various biological responses including immune cell trafficking.

Pathways

SGPP1 functions within the sphingolipid metabolism pathway which is closely tied to the regulation of cellular processes such as proliferation and apoptosis. Its activity has a strong connection with S1P lyase which further degrades sphingosine. SGPP1 also interacts with enzymes involved in the ceramide synthesis pathway reflecting its role in balancing the levels of different sphingolipids that affect cellular functions.

SGPP1 affects conditions such as cancer and inflammation. Its ability to modulate S1P concentrations links it to tumor growth and spread as altered sphingolipid signaling can drive oncogenic processes. An additional association exists with inflammatory disorders where SGPP1 influences immune responses. SGPP1 interacts with SGPL1 another key enzyme in the sphingolipid pathway affecting these disease outcomes.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Specifically dephosphorylates sphingosine 1-phosphate (S1P), dihydro-S1P, and phyto-S1P. Does not act on ceramide 1-phosphate, lysophosphatidic acid or phosphatidic acid (PubMed : 16782891). Sphingosine-1-phosphate phosphatase activity is needed for efficient recycling of sphingosine into the sphingolipid synthesis pathway (PubMed : 11756451, PubMed : 12815058, PubMed : 16782891). Regulates the intracellular levels of the bioactive sphingolipid metabolite S1P that regulates diverse biological processes acting both as an extracellular receptor ligand or as an intracellular second messenger (PubMed : 11756451, PubMed : 12815058, PubMed : 16782891). Involved in efficient ceramide synthesis from exogenous sphingoid bases. Converts S1P to sphingosine, which is readily metabolized to ceramide via ceramide synthase. In concert with sphingosine kinase 2 (SphK2), recycles sphingosine into ceramide through a phosphorylation/dephosphorylation cycle (By similarity). Regulates endoplasmic-to-Golgi trafficking of ceramides, resulting in the regulation of ceramide levels in the endoplasmic reticulum, preferentially long-chain ceramide species, and influences the anterograde membrane transport of both ceramide and proteins from the endoplasmic reticulum to the Golgi apparatus (PubMed : 16782891). The modulation of intracellular ceramide levels in turn regulates apoptosis (By similarity). Via S1P levels, modulates resting tone, intracellular Ca(2+) and myogenic vasoconstriction in resistance arteries (PubMed : 18583713). Also involved in unfolded protein response (UPR) and ER stress-induced autophagy via regulation of intracellular S1P levels (PubMed : 18583713, PubMed : 20798685). Involved in the regulation of epidermal homeostasis and keratinocyte differentiation (By similarity).
See full target information SGPP1

Publications (1)

Recent publications for all applications. Explore the full list and refine your search

Drug development research 83:142-149 PubMed34189759

2021

Overexpression of ARHI increases the sensitivity of cervical cancer cells to paclitaxel through inducing apoptosis and autophagy.

Applications

Unspecified application

Species

Unspecified reactive species

Yang Wang,Fangrong Shen,Jinhua Zhou,Yuelan Fang,Yalan Qi,Youguo Chen
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com